Mangum, Blake R.
Pogue, Jason M.
Barber, Katie E.
Article History
Accepted: 5 January 2024
First Online: 10 February 2024
Compliance with Ethical Standards
:
: BRM owns BioCryst stock. JMP reports grants and personal fees from Merck, GlaxoSmithKline, Shionogi, AbbVie, Entasis, and Melinta outside the submitted work. KEB has no conflicts.
: This article does not contain any studies with human or animal subjects performed by any of the authors.